Driving Productivity in Biotech Clinical Trials

Fortrea
  • 0.0 (0)
  • MEDICINE

In this series, we discuss how to drive productivity in biotech clinical trials and how to maximize valuation for minimal investment. Historically, R&D productivity has always been an area of focus and priority for the industry, but recent trends are particularly challenging. How do you realize this ultimate goal as protocols are becoming increasingly complex?

Episodes

  1. Collaboration Between Contract Research Organizations and Biotech Companies

    08/11/2025

    Collaboration Between Contract Research Organizations and Biotech Companies

    Wrap up our Driving Productivity in Biotech Clinical Trials podcast as we discuss collaboration between Contract Research Organizations and biotech companies, emphasizing the importance of communication and understanding in clinical trials. Participants: Host: Dr. Ken Park, VP of R&D Strategy and Innovation Consulting for Fortrea Tracy Newbold, VP of Clinical Operations at Lexicon Pharmaceuticals Terry Athreya, SVP and Global Head of Clinical Operations for Fortrea Alaric Jackson, Chief Technology and Data Officer at Fortrea

    11 min
  2. Innovative Approaches to Enhance Productivity

    08/11/2025

    Innovative Approaches to Enhance Productivity

    This episode explores innovative approaches to enhance productivity within clinical trials, focusing on the use of technology and data-driven strategies. Participants: Host: Dr. Ken Park, VP of R&D Strategy and Innovation Consulting for Fortrea Tracy Newbold, VP of Clinical Operations at Lexicon Pharmaceuticals Terry Athreya, SVP and Global Head of Clinical Operations for Fortrea Alaric Jackson, Chief Technology and Data Officer at Fortrea

    21 min
  3. How to Maximize Valuation for Minimal Cost

    08/11/2025

    How to Maximize Valuation for Minimal Cost

    In this episode, “How to Maximize Valuation for Minimal Cost,” we explore a critical question: Are you focused on regulatory approval, or on maximizing value? Your answer could determine the path your clinical trial takes, and the outcome it delivers. Participants: Host: Dr. Ken Park, VP of R&D Strategy and Innovation Consulting for Fortrea Tracy Newbold, VP of Clinical Operations at Lexicon Pharmaceuticals Terry Athreya, SVP and Global Head of Clinical Operations for Fortrea Alaric Jackson, Chief Technology and Data Officer at Fortrea

    21 min
  • 3 Episodes

About

In this series, we discuss how to drive productivity in biotech clinical trials and how to maximize valuation for minimal investment. Historically, R&D productivity has always been an area of focus and priority for the industry, but recent trends are particularly challenging. How do you realize this ultimate goal as protocols are becoming increasingly complex?

Information